Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | HK2 | P52789 | 5/20 | 0.45 |
| ▸ | HK1 | P19367 | 4/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | PYGB | P11216 | 6/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Streptozosin SCHEMBL444089 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Streptozosin SCHEMBL18402590 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Streptozosin SCHEMBL4748 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Streptozosin SCHEMBL13840968 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Streptozosin SCHEMBL17327962 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Streptozosin SCHEMBL15012795 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Streptozosin SCHEMBL10201155 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Streptozosin SCHEMBL17328035 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Streptozosin SCHEMBL10262780 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 | |
| Streptozosin SCHEMBL18402588 | 1.00 | LMNA (1.00) | LMNAKDM4ECYP2D6CYP2C19HK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3986 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075693-A | Application of transcription factor CUX1 in preparation of product for preventing and treating diabetic foot ulcer | — | 2026-05-26 | — | — | CN | claimed |
| CN-122074048-A | Methods of treating cancer | 诺华股份有限公司 | 2026-05-22 | — | — | CN | claimed |
| EP-3699174-B1 | COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME | ILAB (KR) | 2025-11-12 | — | — | EP | claimed |
| EP-4642537-A2 | A GLUCOSAMINE COMPOUND AND A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF SUITABLE FOR USE IN THE TREATMENT OF BREAST CANCER AND RELIEF OF SYMPTOMS RESULTING FROM SUCH DISEASES | Mugla Sitki Kocman Universitesi Strateji Gelistirme Daire Baskanligi (TR) | 2025-11-05 | — | — | EP | claimed |
| EP-4026563-B1 | CONDITIONING PROTOCOLS AND USE OF SAME FOR TISSUE REGENERATION | YEDA RES & DEV (IL) | 2025-10-29 | — | — | EP | claimed |
| EP-4045493-B1 | COMPOUNDS FOR TARGETED DEGRADATION OF CARRIER PROTEINS AND USES THEREOF | CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH (AT) | 2025-08-13 | — | — | EP | claimed |
| EP-3883929-B1 | 4,5,6,7-TETRAHYDRO-L-BENZOTHIOPHENE MODULATORS OF RETINOIC ACID RECEPTOR RELATED (RAR) ORPHAN NUCLEAR RECEPTORS (RORS) | 11949098 CANADA INC (CA) | 2025-06-04 | — | — | EP | claimed |
| CN-119780014-A | Method for detecting levofloxacin in wastewater by ultraviolet dual-wavelength | 中国科学院大连化学物理研究所 | 2025-04-08 | — | — | CN | claimed |
| WO-2025068850-A1 | METHOD OF TREATING CANCER | NOVARTIS AG (CH) | 2025-04-03 | — | — | WO | claimed |
| CN-119679973-A | Method for improving liver function injury caused by diabetes | 青岛农业大学 | 2025-03-25 | — | — | CN | claimed |
| US-11529334-B2 | Pharmaceutical composition for treating or preventing Parkinson's disease comprising STT as an active ingredient | GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2022-12-20 | — | — | US | claimed |
| WO-2022169634-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | UNM RAINFOREST INNOVATIONS (US) | 2022-08-11 | — | — | WO | claimed |
| EP-3539971-B1 | RUTHENIUM COMPLEXES FOR TREATING CANCER WHICH COMPRISES CANCER STEM CELLS | UNIV SANTIAGO COMPOSTELA (ES) | 2022-07-20 | — | — | EP | claimed |
| EP-3734280-B1 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | ASTUTE MEDICAL INC (US) | 2022-06-01 | — | — | EP | claimed |
| CN-114470324-A | Novel strategy for the modification of universal bone implants for the intervention of bone defects associated with diabetes | 福建医科大学附属协和医院 | 2022-05-13 | — | — | CN | claimed |
| CN-114470177-A | Novel cerium mediated co-assembled multifunctional nanoenzyme (CHA @ GOx) for use in diabetic wound treatment | 重庆医科大学 | 2022-05-13 | — | — | CN | claimed |
| EP-3986463-A1 | A CONJUGATE OF A CYTOTOXIC AGENT TO A CELL BINDING MOLECULE WITH BRANCHED LINKERS | Hangzhou Dac Biotech Co., Ltd. (CN) | 2022-04-27 | — | — | EP | claimed |
| WO-2022060993-A1 | SYSTEM AND METHOD FOR INTEGRATED BLOOD VESSEL EMBOLIZATION AND LOCALIZED DRUG DELIVERY | FARHA SAID (US) | 2022-03-24 | — | — | WO | claimed |
| EP-3294303-B1 | PANCREATIC STROMAL PROGENITOR CELLS | ALFRED E MANN INSTITUTE FOR BIOMEDICAL ENGINEERING AT THE UNIV OF SOUTHERN CALIFORNIA (US) | 2022-02-16 | — | — | EP | claimed |
| US-5691307-A | ANTITUMOR AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-11-25 | — | — | US | claimed |